期刊文献+

白血病细胞系中抑癌基因PTEN启动子区甲基化状态检测及其去甲基化研究 被引量:7

Promoter methylation status of PTEN gene and the effect of induced demethylation in leukemia cell lines
原文传递
导出
摘要 目的探讨抑癌基因PTEN表达沉默的机制及诱导PTEN表达对白血病细胞的作用。方法应用甲基化特异性聚合酶链反应(Methylation specific PCR,MSP)检测白血病细胞系HL-60、Nalm-6、Raji、KG-1a、U937、NB4、K562中PTEN基因启动子区域甲基化状态;用甲基化转移酶抑制剂5-氮-2’-脱氧胞苷(5-Aza-CdR)处理白血病细胞,MSP检测甲基化状态的改变、RT-PCR检测PTEN mRNA水平的改变、瑞特染色观察细胞形态学改变、膜联蛋白V/碘化丙锭(Annexin V/PI)标记染色检测细胞凋亡。结果检测的白血病细胞系中HL-60、Nalm-6、Raji、KG-1a、U937细胞PTEN基因显示超甲基化状态,而NB4和K562细胞显示低甲基化状态;5-Aza-CdR处理HL-60和Nalm-6细胞后,PTEN基因甲基化降低、mRNA表达水平则逐渐增高,并呈剂量依赖性,细胞出现凋亡现象。结论PTEN基因启动子区异常甲基化可能导致该基因转录表达失活或沉默,甲基化抑制剂可以诱导PTEN表达,并引起白血病细胞凋亡。 Objective To explore the mechanism of PTEN gene expression silence in leukemia cells, and the effect of induced PTEN gene expression in leukemia cells. Methods Methylation status of PTEN in leukemic cell lines, including HL-60, Nalm-6, NB4, U937, Raji, K562 and KG-1a was assessed by methyl- ation specific PCR (MSP). The cell lines were then treated with different concentrations of methyltransferase inhibitor 5-Aza-2'-deoxycytidine(5-Aza-CdR). After that the changes in PTEN methylation status were detected by MSP, and PTEN mRNA expression level by reverse transcription PCR (RT-PCR). Growth inhibition and apoptosis of HL-60 and Nalm-6 cells induced by 5-Aza-CdR were observed by MTT assay, and Wright and Annexin V staining, respectively. Results Hypermethylation of PTEN promoter was detected in HL-60, U937, Nalm-6, Raji and KG-1a, while hypomethylation was found in NB4 and K562 by MSP. After 5-Aza- CdR treatment, the hypermethylation status of PTEN promoter in HL-60 and Nalm-6 cells was reversed and their PTEN mRNA expression levels were up regulated in dose dependent manner with the 5-Aza-CdR concentrations, and the cell apoptosis was induced. Conclusion Hypermethylation in the promoter region is one of major mechanisms responsible for transcriptional suppression of PTEN. Methyhransferase inhibitor could induce the expression of PTEN gene and lead to the leukemia cells apoptosis.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第5期289-292,共4页 Chinese Journal of Hematology
基金 天津市科技发展计划项目(05YFSZSF02400) 国家高技术研究发展计划(2006AA02A405)
关键词 白血病 基因 PTEN 甲基化 特异性聚合酶链反应 5-氮-2’-脱氧胞苷 Leukemia Gene, PTEN Methylation Methylation specific PCR(MSP) 5- Aza-2'-deoxycytidine
  • 相关文献

参考文献15

  • 1沈权,陈泽,刘旭萍,邢海燕,王敏,王建祥.抑癌基因PTEN mRNA在白血病细胞中的表达及意义[J].中华血液学杂志,2005,26(8):493-496. 被引量:20
  • 2Salvesen HB, MacDonald N, Ryan A, et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer, 2001, 91:22-26.
  • 3Risinger JI, Hayes AK, Berchuck A, et al. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res, 1997, 57:4736-4738.
  • 4张天一,安君岭,顾君一,何松.肝细胞癌中PTEN、Cx43及VEGF蛋白的表达[J].癌症,2004,23(6):662-666. 被引量:14
  • 5Idoate MA, Sofia E, Lozano MD, et al. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas. Diagn Mol Pathol, 2003, 12: 160- 165.
  • 6Chung MJ, Jung SH, Lee B J, et al. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer. Pathol Int, 2004, 54:10-15.
  • 7Koenig A, Bianco SR, Fosmire S, et al . Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma. Vet Pathol, 2002, 39: 458-472.
  • 8Tanaka Y, Gavrielides MV, Mitsuuchi Y, et al. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem, 2003,278 : 33753-33762.
  • 9Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 1998, 280: 1614-1617.
  • 10Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogeni.c effects. J Biol Chem, 2002, 277 : 10760-10766.

二级参考文献19

  • 1Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration,spreading, and focal adhesions by tumor suppressor PTEN. Science,1998, 280: 1614-1617.
  • 2Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem, 1998, 273:13375-13378.
  • 3le Good JA, Ziegler WH, Parekh DB, et al. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science, 1998, 281: 2042-2045.
  • 4Wu RC, Li X, Schonthal AH. Transcriptional activation of p21WAF1by PTEN/MMAC1 tumor suppressor. Mol Cell Biochem, 2000, 203:59-71.
  • 5Zhu X, Kwon CH, Schlosshauer PW, et al. PTEN induces G ( 1 )cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res, 2001,61:4569-4575.
  • 6Moon SK, Kim HM, Kim CH. PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys, 2004,421:267-276.
  • 7Terakawa N, Kanamori Y, Yoshida S. Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer. Endocr Relat Cancer, 2003,10: 203-208.
  • 8Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [J]. Science, 1997, 275(5308): 1943 - 1947.
  • 9Noguchi M, Nomata K, Watanabe J, et al. Changes in the gap junctional intercellular communication in the renal tubular epithelial cells in vitro treated with renal carcinogens [J]. Cancer Lett, 1998, 122(1 -2):77 -84.
  • 10Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis [J] . Kindey International, 1999, 56(3): 794 -814.

共引文献32

同被引文献70

  • 1李锋,陈朴,邹善华.慢性髓细胞性白血病与血管生成因子关系[J].中国癌症杂志,2004,14(5):462-465. 被引量:4
  • 2沈权,陈泽,刘旭萍,邢海燕,王敏,王建祥.抑癌基因PTEN mRNA在白血病细胞中的表达及意义[J].中华血液学杂志,2005,26(8):493-496. 被引量:20
  • 3Myers MP, Stolarov JP, Eng C, et al. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase[J] . Proc Natl Acad Sci USA, 1997, 94(17): 9052 - 9057.
  • 4Dahia PL, Aguiar RC, Alberta J, et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies[J]. Hum Mol Genet, 1999,8(2) : 185- 193.
  • 5Cheong JW , Eom JI, Maeng HY, et al. Phosphatase and tensin homologue phosphorylation in the C-term inal regulatory domain is frequently observed in acute myeloid leukaem ia and associated with poor clinical outcome[J]. Br J Haematol,2003, 122(3) :454- 456.
  • 6Martelli AM, Tazzari PL, Evangelisti C, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside[J]. Curr Med Chem, 2007, 14(19) :2009- 2023.
  • 7TamuraM, Gn J, Darien EH, et al. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix dependent phosphatidylinositol 3-kinade/Akt cell survival pathway [J]. J Biol Chem, 1999, 274(29) :20693- 20703.
  • 8Ly C,Arechiga AF,Melo JV,et al. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin [ J ]. Cancer Res, 2003,63 (18) : 5716 - 5722.
  • 9Hirano I, Nakamura S, Yokota D. Depletion of pleckstrin homology domain leucine-rich repeat protein phosphatase 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms [J]. J Biol Chem, 2009,284(33) :22155- 22165.
  • 10McCubrey JA, Steelman LS, Abrans SE, et al.Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK,PI3K/PIEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy [ J ]. Leukemia, 2008,22 (4) : 708 - 722.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部